A group of scientists from the Angiogenesis Unit of the Biomedical Research Centre of La Rioja (CIBIR) has succeeded in creating a vaccine, based on messenger RNA technology, that ...

Approximately 40% of the European population are allergic to pollen, and their symptoms cause an estimated loss of 100 ...

High dietary inflammatory index (DII), which quantifies the inflammatory potential of diet, is associated with increased ...

A large-scale bibliometric analysis maps global research on hydrogels as next-generation drug delivery systems for cancer ...

Researchers developed a nasal antibody that blocks mugwort pollen, a major hay fever trigger in Europe and Central Asia.

IncellDx, a precision medicine company, today announced the journal Frontiers in Immunology has published a study detailing a framework for understand ...

The first thing that comes to mind with the word trained immunity is the immunological training every immune cell acquired during the entire lifespan of an ...

"Eleva commences Phase I clinical trial for C3G treatment" was originally created and published by Clinical Trials Arena, a ...

Infinity Bio, the leader in antibody reactome profiling, is announcing the launch of EnviroSIGHT™, the world’s first ...

Immune disorders are a leading cause of morbidity and long-term health challenges among children worldwide. Recent decades ...

Frontiers in Immunology is a leading journal in its field, publishing rigorously peer-reviewed research across basic, translational and clinical immunology.

A team has demonstrated in theory that a protein antigen from a childhood vaccine can be delivered into the cells of a malignant tumor to refocus the body's immune system against the cancer ...